SR ONE CAPITAL MANAGEMENT, LP Q4 2023 Filing

Filed February 12, 2024

Portfolio Value

$238.2B

Holdings

5

Report Date

Q4 2023

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ACLXARCELLX INC.
3,146,630$174.6B73.33%
2
SPRYARS PHARMACEUTICALS
4,012,903$22.0B9.23%
3
DSGNDESIGN THERAPEUTICS INC
6,526,476$17.3B7.26%
4
MLYSMINERALYS THERAPEUTICS
1,794,600$15.4B6.48%
5
NKTXNKARTA INC.
1,333,333$8.8B3.70%